News

Er-Kim and CNX Therapeutics Forge Groundbreaking Partnership

Er-Kim and CNX Therapeutics Forge Groundbreaking Partnership

Groundbreaking Partnership Announcement

Er-Kim, an international pharmaceutical enterprise known for its expertise in novel therapies, has announced a significant partnership with CNX Therapeutics. This exclusive agreement focuses on distributing a selection of oncology products across Central and Eastern Europe (CEE) and Türkiye, marking a pivotal step for both companies.

Exclusive Distribution Agreement

The agreement positions Er-Kim as the exclusive distributor of CNX Therapeutics' oncology medication portfolio, which includes established products like Cardioxane and Savene. These treatments are set to enhance the oncology landscape across CEE, ensuring that patients have better access to essential therapies.

The Role of Er-Kim in Oncology

With over 40 years of experience in the pharmaceutical industry, Er-Kim has built a reputation as a trusted provider of oncology treatments within the region. Mert Zorlular, President & CFO of Er-Kim, expressed enthusiasm for this collaboration, highlighting the commitment to improving the quality of life for cancer patients through effective therapeutic solutions.

Strengthening Global Reach

This partnership not only enhances the portfolio available to healthcare providers but also allows CNX Therapeutics to tap into Er-Kim's well-established distribution network in Central and Eastern Europe. According to Pete Butterfield, Chief Operating Officer at CNX Therapeutics, the collaboration is a strategic move to broaden their market access and meet the needs of patients more effectively.

About Er-Kim

Founded in 1981, Er-Kim leads in biopharmaceutical innovation and commercialization. Partnered with over 40 global pharmaceutical leaders, Er-Kim's portfolio includes more than 68 products distributed across over 50 countries, showing their commitment to overcoming international healthcare challenges. The company boasts a dedicated workforce of over 300 professionals and impressive annual revenues exceeding EUR 305 million.

About CNX Therapeutics

CNX Therapeutics is committed to improving patient lives through access to essential medications. This specialty pharmaceutical company focuses on a range of therapeutic areas across over 60 markets worldwide. Their portfolio includes solutions for neurological, psychiatric, and critical care scenarios, positioning them as a key player in the global pharmaceutical landscape.

Contact Information

For media inquiries regarding this significant partnership, please contact:

Rosalia Scampoli
Marketcom PR
Tel: (914) 815-1465
Email: rscampoli@marketcompr.com

Mehdi Juma
CNX Communications Manager
Email: mehdi.juma@cnx-therapeutics.com

Frequently Asked Questions

What is the nature of the partnership between Er-Kim and CNX Therapeutics?

Er-Kim and CNX Therapeutics have entered into an exclusive agreement to distribute oncology products across Central and Eastern Europe and Türkiye.

What products will be included in this distribution agreement?

The agreement includes oncology medications such as Cardioxane and Savene from CNX Therapeutics' established portfolio.

When was Er-Kim founded?

Er-Kim was established in 1981 and has become a leader in biopharmaceutical innovation.

How many professionals does Er-Kim employ?

Er-Kim has a dedicated team of over 300 professionals working globally.

What is CNX Therapeutics' focus area?

CNX Therapeutics specializes in providing essential medicines for neurological, psychiatric, and critical care, with a commitment to ethical standards and sustainability.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 2

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Alex Jones Returns to Austin: New Studio, New Plans

Updated Category News Views 3

Back in the Saddle: Austin's Controversy Stirs Again It looks like we're seeing a new chapter in a saga that just refuses to end. Alex Jones, the infamous firebrand who's plastered conspiracy theories across the airwaves for two decades, is returning to ground zero in Austin—the old InfoWars studio. After wading through bankruptcy muck and courtroom clashes, Jones is...

Continue Reading
Catalina Behavioral Health: 4 Years, 1,000 Lives Touched

Updated Category News Views 3

Pioneering Care in Behavioral Health Catalina Behavioral Health is proving that four years can make a difference. From their base in Tucson, they've grown to serve 1,000 souls navigating the stormy waters of addiction and mental health. It's not just about numbers, you see—this milestone marks real lives changed, one battle at a time. Building Trust, One Patient at a...

Continue Reading
VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Updated Category News Views 4

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Continue Reading
Newmark's $482.5M Loan Fuels Steamboat Resort Expansion

Updated Category News Views 4

Newmark Banks on Steamboat's Future Diving headfirst into the deep end, Newmark (NASDAQ: NMRK) just roped in a colossal $482.5 million loan for a new gem in Steamboat Springs, Colorado. Inking a deal of this magnitude ain't your everyday rinse-and-repeat; it's a bold move that speaks volumes about where the big shots think value's heading. The Financial Fuel: GoldenTree...

Continue Reading
Miguel Pantoja: Wiring a Second Chance Beyond Bars

Updated Category News Views 3

A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...

Continue Reading
Stravito's MCP Server Revolutionizes AI in Business

Updated Category News Views 5

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Continue Reading
Mattamy Homes Earns Spot as Top Workplace in Jacksonville

Updated Category News Views 8

Jacksonville's Housing Scene Gets a Boost In a world where everyone seems bent on working down to the bone to climb some imaginary corporate ladder, here comes Jacksonville's own Mattamy Homes with a news flash—it's possible to work, live, and still smile at the end of the day. Recently, they earned themselves a coveted spot among the best workplaces in Jacksonville for...

Continue Reading
AMD CEO, Global Leaders Converge At IMPERIA Summit

Updated Category News Views 3

A Clash of Giants in New York The trade floors are buzzing in New York as the world's economic heavyweights and tech titans gather for the inaugural IMPERIA Summit. You can almost smell the pressure and ambition wafting through the streets when folks like AMD's CEO, Lisa Su, share the stage with geopolitical power players like President Trump and China's President Xi...

Continue Reading
Decision Logic Innovates with Vitals & ShiftFlow Tools

Updated Category News Views 4

Restaurant Battlefields: The Need for Real-Time Response Running a restaurant is no walk in the park. One slip, and you're dealing with spoiled soup or crabby customers. Decision Logic reckons they've cracked the code to smoother operations with their new tools, Vitals and ShiftFlow. At heart, these products do one thing: put critical data into the hands of managers while...

Continue Reading

Top 5 Most Recently Viewed Articles

Will Smith Shines at Middle East Premiere of Unique Series

Updated Category News Views 136

Will Smith Shines at Middle East Premiere of Unique Series Will Smith, a global entertainment icon, captivated audiences at the much-anticipated Middle East premiere of Pole to Pole with Will Smith. This significant event was held at the SEE Institute, recognized as the region's first net-zero emissions building located within The Sustainable City. The gathering united a...

Continue Reading
Voyager Technologies Takes Steps Towards IPO with SEC Filing

Updated Category News Views 752

Voyager Technologies Pursues Initial Public Offering In a significant move, Voyager Technologies has confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission (SEC). This step is crucial for the company as it aims to initiate a public offering of its common stock. While details regarding the number of shares or the...

Continue Reading
Dot Inc. and WEBTOON Bring Comics to Life for All Readers

Updated Category News Views 243

Innovative Partnership Expands Comic Accessibility In a groundbreaking collaboration, WEBTOON Entertainment and Dot Inc. have joined forces to innovate how visually impaired audiences can access popular webcomics. This partnership aims to turn beloved WEBTOON titles like "Yumi's Cells" and "Hooky" into tactile digital formats that can be read in braille on the Dot Pad, a...

Continue Reading
Orsini Partners with Crinetics for Innovative Acromegaly Treatment

Updated Category News Views 253

Orsini's Role in Acromegaly Treatment Orsini has been selected as the specialty pharmacy partner for Crinetics Pharmaceuticals, Inc., to provide PALSONIFY™ (paltusotine), a groundbreaking therapy for treating acromegaly. This new oral therapy is designed for adults who either did not respond adequately to surgery or for whom surgical intervention is not viable. The...

Continue Reading
Investors Can Join Class Action in DeFi Technologies Case

Updated Category News Views 98

Investors Encouraged to Step Forward for DeFi Technologies Case In light of significant developments regarding DeFi Technologies Inc. (NASDAQ: DEFT), a call to action has emerged for investors affected by misleading information related to the company's performance. With a class action lawsuit now filed, those who purchased securities of the company during the specified...

Continue Reading